Literature DB >> 14579512

Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action.

Henry A Lester1, Carlos Fonck, Andrew R Tapper, Sheri McKinney, M Imad Damaj, Seth Balogh, Jeremy Owens, Jeanne M Wehner, Allan C Collins, Cesar Labarca.   

Abstract

Two series of knockin mouse strains have been constructed with point mutations that result in hypersensitive neuronal nicotinic acetylcholine receptors containing alpha 4- or alpha 7-subunits. The full expression of the stronger alleles produces neonatal excitotoxic lethality; however, mice with attenuated expression or milder alleles are viable, and display a range of hypersensitive responses to nicotine. To date, measurements have been made on nicotine-induced seizures, Straub tail, hypothermia, antinociception, electroencephalograms and cellular electrophysiological responses. These strains are helping to define the occurrence of these important receptor subtypes, and their role in the acute and chronic actions of nicotine. The hypersensitive strains may be useful for the development of nicotinic drug therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579512

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  13 in total

1.  3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of human α4β2 neuronal nicotinic acetylcholine receptors.

Authors:  Brandon J Henderson; Crina M Orac; Iwona Maciagiewicz; Stephen C Bergmeier; Dennis B McKay
Journal:  Bioorg Med Chem Lett       Date:  2011-11-20       Impact factor: 2.823

2.  Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.

Authors:  Cheng Xiao; Julie M Miwa; Brandon J Henderson; Ying Wang; Purnima Deshpande; Sheri L McKinney; Henry A Lester
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

3.  Nicotinic acetylcholine receptors containing the α4 subunit modulate alcohol reward.

Authors:  Liwang Liu; Linzy M Hendrickson; Melissa J Guildford; Rubing Zhao-Shea; Paul D Gardner; Andrew R Tapper
Journal:  Biol Psychiatry       Date:  2012-11-09       Impact factor: 13.382

Review 4.  Genetic matters: thirty years of progress using mouse models in nicotinic research.

Authors:  Michael J Marks
Journal:  Biochem Pharmacol       Date:  2013-06-06       Impact factor: 5.858

Review 5.  Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations.

Authors:  Ryan M Drenan; Henry A Lester
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

6.  A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior.

Authors:  Lindsey G Soll; Sharon R Grady; Outi Salminen; Michael J Marks; Andrew R Tapper
Journal:  Neuropharmacology       Date:  2013-05-17       Impact factor: 5.250

7.  Nicotinic acetylcholine receptor expression in the hippocampus of 27 mouse strains reveals novel inhibitory circuitry.

Authors:  Lorise C Gahring; Scott W Rogers
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

8.  Mouse chromosome 11 harbors genetic determinants of hippocampal strain-specific nicotinic receptor expression.

Authors:  Scott W Rogers; Janis J Weis; Ying Ma; Cory Teuscher; Lorise C Gahring
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

10.  Dopamine D2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive {alpha}4 nicotinic receptors via a cholinergic-dependent mechanism.

Authors:  Rubing Zhao-Shea; Bruce N Cohen; Herwig Just; Tristan McClure-Begley; Paul Whiteaker; Sharon R Grady; Outi Salminen; Paul D Gardner; Henry A Lester; Andrew R Tapper
Journal:  FASEB J       Date:  2009-08-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.